ResearcherChinese Academy of Medical Sciences & Peking Union Medical CollegeNo recent work listed

Dandan Hu

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0009-0002-6576-5410; OpenAlex author ID A5002773690. Sources: OpenAlex.

Their work

Papers: 2 (first author 1, last author 0)
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 4

Papers, trials and grants by year

2017: 1 paper · 2018: none · 2019: none · 2020: 1 paper

Papers 2

The Serum MicroRNA Signatures for Pancreatic Cancer Detection and Operability Evaluation. First author DOI 10.3389/fbioe.2020.00379 ↗
[Progress in neoadjuvant and transformation therapy of pancreatic cancer]. Co-author DOI 10.3760/cma.j.issn.0529-5815.2017.01.018 ↗

Closest collaborators

The 4 strongest of 4 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Meng Dai · 1 shared paper, 2017 · strength 0.15
- Paper [Progress in neoadjuvant and transformation therapy of pancreatic cancer]. DOI 10.3760/cma.j.issn.0529-5815.2017.01.018 ↗
Qiuliang Yan · 1 shared paper, 2020 · strength 0.11
- Paper The Serum MicroRNA Signatures for Pancreatic Cancer Detection and Operability Evaluation. DOI 10.3389/fbioe.2020.00379 ↗
Yan Chen · 1 shared paper, 2020 · strength 0.11
- Paper The Serum MicroRNA Signatures for Pancreatic Cancer Detection and Operability Evaluation. DOI 10.3389/fbioe.2020.00379 ↗
Jinhui Zhu · 1 shared paper, 2020 · strength 0.11
- Paper The Serum MicroRNA Signatures for Pancreatic Cancer Detection and Operability Evaluation. DOI 10.3389/fbioe.2020.00379 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.